Heart Failure
Devices and Surgical Techniques Learning Series
Cardiogenic Shock and Mechanical Circulatory Support
Episodes
Staged Strategic Treatment Pathway During Unique Biventricular Failure Case
10 min.
Tinkering the Ticker: TandemHeart to TAVR
10 min.
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre Cardiogenic Shock
12 min.
Assessing RV Function in Cardiogenic Shock: When to Pull the Trigger on MCS
8 min.
Role of Temporary MCS in Pulmonary Arterial Hypertension
9 min.
Acute MR With MCS/TEER
6 min.
Aortic Stenosis With Acute LV Unloading With Septostomy
13 min.
Cardiogenic Shock With MCS and Review of Shock Algorithm
6 min.
Cardiogenic Shock: ECMO Supported TAVR
12 min.
Influence of Body Surface Area, and Ventricular Dimensions on Impella 5.5 Outcomes
9 min.
Pulmonary Artery Catheter Use in Patients with Heart Failure Cardiogenic Shock (HF-CS): An Analysis from the Cardiogenic Shock Working Group (CSWG)
9 min.
Application of Exception from Informed Consent to a Multicenter Cardiogenic Shock Trial
9 min.
Hot Topics on Regulatory Issues in Caridiogenic Shock - FDA Perspective
8 min.
How Narrow or Broad Should Enrollment Criteria Be in Trials on Cardiogenic Shock to Achieve Clinically Interpretable Results?
7 min.
How Tightly Should Treatment Algorithms Be Prescribed in a Clinical Trial on Cardiogenic Shock? What Are The Key Treatment Protocol Elements?
9 min.
Artificial Intelligence Will Revolutionize Risk Stratification and Guide Therapy for Cardiogenic Shock
7 min.
Biomarkers and Risk Stratification for Cardiogenic Shock
7 min.
How SCAI Classification Has Revolutionized Approach to Cardiogenic Shock
7 min.
Treating the Right Ventricle in Cardiogenic Shock: the Next Frontier in Improving Outcomes
7 min.
Intra-Aortic Balloon Counterpulsation: "I'll Be Back"
7 min.
Trans-Valvular LV Support: a Glimpse Into the Future
9 min.
What Do We Really Know About ECMO in Cardiogenic Shock?
8 min.
When To Transition From Medical to Device-Based Therapy
8 min.
SEISMiC Trial: Isatroxime (lusi-inotrope) (HF shock)
6 min.
SSO2 for AMI Shock: The ISO-Shock Trial (AMI)
7 min.
Should All ECMO Patients Receive LV Unloading (Include HYPO-ECMO)?
10 min.
Impella for Cardiogenic Shock: High Expectations From Ongoing Studies
9 min.
Cardiogenic Shock: Customized Therapeutic Approaches in 2023
8 min.
Cardiogenic Shock: Patient Phenotyping and Prognostication
7 min.
Take Care of the Patient as Close to Home as Possible
5 min.
We Need Shock and Arrest Centers (Pro)
5 min.
MCS in Cardiogenic Shock: Use It Selectively
15 min.
MCS in Cardiogenic Shock: Use It Routinely
5 min.
Con: Cardiogenic Shock Therapy Need Not Be Guided by Pulmonary Artery Catheter
9 min.
Pro: Cardiogenic Shock Therapy Must Be Guided by Pulmonary Artery Catheter
6 min.
State-of-the-art Lecture on Evidence for MCS in Cardiogenic Shock
11 min.
When to Perform Venting in VA-ECMO
11 min.
MCS in Shock: Choosing the Right Device Based on Hemodynamic Criteria
10 min.
MCS in Shock: Access Site Selection and Prevention of Access Site Complications
14 min.
Optimal Antithrombotic Strategies in MCS Use
10 min.
RV Support: When and How?
12 min.
The Conundrum of Clinical Trials in Cardiogenic Shock
16 min.
Con: VA-ECMO is not the Option of Choice for Cardiogenic Shock
14 min.
Pro: The IABP is the First-line MCS for Non-AMI Cardiogenic Shock
5 min.
Con: The IABP is not a First-line MCS for Non-AMI Cardiogenic Shock
14 min.
Pro: Percutaneous LVADs are the First Line MCS device of choice for Acute MI & Cardiogenic Shock
6 min.
Con: Percutaneous LVADs are not the First Line MCS device of choice for Acute MI & Cardiogenic Shock
15 min.
Pro: VA-ECMO is the Option of Choice for Cardiogenic Shock
5 min.
Pro: Most Patients With AMI Cardiogenic Shock Should Get MCS (Randomization Is Unethical)
6 min.
Con: Favorable Data Is Lacking on MCS in AMI Cardiogenic Shock (Randomized Data Are Needed)
17 min.
Coronary Keynote Lecture: When and How to Choose IABP, Impella, TandemHeart, or ECMO in CS
8 min.
TCT 611: Amniotic Fluid Embolism-Induced Cardiopulmonary Collapse Successfully Treated with Combination VA-ECMO and Impella CP
6 min.
TCT 688: An Unfortuante Trifecta: A case of acute myocardial infarction with cardiogenic shock, pericardial tamponade, and worsening hypoxia with right to left shunt after percutaneous LVAD placement.
6 min.
TCT 640: POST MYOCARDIAL INFARCTION VENTRICULAR SEPTAL RUPTURE WITH HEART FAILURE AND CARDIOGENIC SHOCK : CHALLENGES AND DEVICE CLOSURE
6 min.
TCT 808: Cardiogenic Shock and Severe MR treated with NTW MitraClip: Bridge to stabilization - GDMT
5 min.
TCT 774: Transcatheter Edge-to-Edge Repair in Primary Severe Mitral Regurgitation Complicated by Cardiogenic Shock
5 min.
TCT 638: Sequential transcatheter treatment of severe mitral and aortic regurgitation with MitraClip and JenaValve Trilogy in a patient with cardiogenic shock
5 min.
Cardiogenic Shock Trials: Defining the Clinical Need and Framing the Issues
10 min.
Is There a Role for MCS in Massive PE and Which Modality?
8 min.
Assembling the Safest Solution for Hemodynamic Support in Heart Failure (Puzzle Medical)
8 min.